** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322) ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322) ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322)
** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322) ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322) ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322)

Press Briefing: Re-NAFFDAC approves GLUCOZIL, AAU’s herbal medicine for diabetes

The Agency’s attention has been drawn to a publication on August 24th, 2023, circulating in many print and online media which claims that a Listed Local Herbal Medicine “Glucozil” produced by Ambrose Alli University Ekpoma was approved by NAFDAC for the treatment and cure of Diabetes Mellitus and capable of treating Benign prostatic hyperplasia (Prostrate […]

Press Briefing On Reported Decline In Pharmaceutical Imports Into Nigeria

, The attention of the Management of the National Agency for Food and Drug Administration and Control (NAFDAC) has been drawn to publications in online tabloid, specifically the Business Day edition of 24th August 2023 titled “Nigeria’s Pharmaceutical Import drop 63% in Two Years”. While the write up quoted this data from the International Trade […]

Public Alert No. 30/2023 – Alert on Four Products found to Contain Potent Medicinal Ingredients Including Steroids and Banned Substances

, The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public of a press release by Health Sciences Authority (HSA) Singapore, on four products found to contain potent medicinal ingredients including steroids and banned substances. The implicated potent medicinal ingredients are not allowed in the affected products and may cause […]

Public Alert No. 028/2023 – Chinese Authorities Suspend Three Cosmetic Production Licenses

, The National Agency for Food and Drugs Administration and Control (NAFDAC) is informing the public that the Chinese Authorities, on 9th May, 2023, suspended cosmetic production licenses of three (3) companies. The suspension was due to violation of relevant regulations, quality and standards. The affected companies are: Huizhou Aozi Cosmetics Co. Ltd, Guangzhou Shangpin […]

Public Alert No. 026/2023 – Alert on Counterfeit Peak Milk in Circulation

, The National Agency for Food and Drug Administration and Control (NAFDAC) is notifying the public of the sale of counterfeit Peak 14g Instant Milk Powder across states in Nigeria. On investigation by the Friesland Campina WAMCO Security team, it was discovered that the counterfeited products displayed openly in the market were few as the […]

Press Briefing: Re-NAFFDAC approves GLUCOZIL, AAU’s herbal medicine for diabetes

, The Agency’s attention has been drawn to a publication on August 24th, 2023, circulating in many print and online media which claims that a Listed Local Herbal Medicine “Glucozil” produced by Ambrose Alli University Ekpoma was approved by NAFDAC for the treatment and cure of Diabetes Mellitus and capable of treating Benign prostatic hyperplasia […]